Cogent Biosciences, Inc. Common Stock (COGT) Financials
Key financial figures for Cogent Biosciences, Inc. Common Stock (Q1 2026).
- Revenue
- $0
- Net Income
- -$97M
- EPS
- $-0.53
- Total Assets
- $903M
- Operating Cash Flow
- -$87M
Full income statement, balance sheet, and cash flow for Cogent Biosciences, Inc. Common Stock on SentiSense.